Artificial intelligence can transform medicine in a myriad of ways, including its promise to act as a trusted diagnostic aide to busy clinicians.
PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney | Psychedelic Invest
PharmAla Biotech Holdings Inc. (CSE: MDMA / OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA),